ENDPOINTS

Genentech's TNKase gets new approval; Sanofi gives up rights to oncology candidate

Plus, news about Nuvation Bio and Leqembi: Sanofi gives back rights to Biond Biologics’ oncology candidate: The French pharma giant put down $125 million upfront in 2021 ...

Mar 3, 2025 - 21:27
 0
Genentech's TNKase gets new approval; Sanofi gives up rights to oncology candidate
Plus, news about Nuvation Bio and Leqembi: Sanofi gives back rights to Biond Biologics’ oncology candidate: The French pharma giant put down $125 million upfront in 2021 ...
Read More

Tags:

Previous Article

US science is under threat ― now scientists are fighting back

Next Article

Candy-colored atoms shine in new image of the Veil Nebula

Related Posts

Pain biotech Latigo eyes up to $150M raise following Vertex's landmark FDA nod

Pain biotech Latigo eyes up to $150M raise following Ve...

Feb 18, 2025  0

CDC investigating hospitalizations after chikungunya vaccination

CDC investigating hospitalizations after chikungunya va...

Feb 27, 2025  0

AbbVie wins FDA approval for new antibiotic

AbbVie wins FDA approval for new antibiotic

Feb 9, 2025  0